Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

The new sprayable wound mask helps heal wounds without scars.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Colectomy led to hair regrowth in a Crohn's patient with alopecia areata.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

L. plantarum MTCC 1325 may help improve memory and cognitive functions in Alzheimer's.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

PRP treatment may help with alopecia areata, especially in newer cases.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Blood metabolites significantly influence alopecia areata risk.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Non-drug therapies show promise for hair regrowth but need more research.